187 related articles for article (PubMed ID: 37158111)
1. Effectiveness of irinotecan plus trabectedin on a desmoplastic small round cell tumor patient-derived xenograft.
Zuco V; Pasquali S; Tortoreto M; Percio S; Doldi V; Barisella M; Collini P; Dagrada GP; Brich S; Gasparini P; Fiore M; Casanova M; Frezza AM; Gronchi A; Stacchiotti S; Ferrari A; Zaffaroni N
Dis Model Mech; 2023 Jun; 16(6):. PubMed ID: 37158111
[TBL] [Abstract][Full Text] [Related]
2. Trabectedin-irinotecan, a potentially promising combination in relapsed desmoplastic small round cell tumor: report of two cases.
Ferrari A; Chiaravalli S; Bergamaschi L; Nigro O; Livellara V; Sironi G; Gasparini P; Pasquali S; Zaffaroni N; Stacchiotti S; Morosi C; Massimino M; Casanova M
J Chemother; 2023 Apr; 35(2):163-167. PubMed ID: 35470779
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of action of trabectedin in desmoplastic small round cell tumor cells.
Uboldi S; Craparotta I; Colella G; Ronchetti E; Beltrame L; Vicario S; Marchini S; Panini N; Dagrada G; Bozzi F; Pilotti S; Galmarini CM; D'Incalci M; Gatta R
BMC Cancer; 2017 Feb; 17(1):107. PubMed ID: 28166781
[TBL] [Abstract][Full Text] [Related]
4. Trabectedin and irinotecan combination regresses a cisplatinum-resistant osteosarcoma in a patient-derived orthotopic xenograft nude-mouse model.
Higuchi T; Miyake K; Oshiro H; Sugisawa N; Yamamoto N; Hayashi K; Kimura H; Miwa S; Igarashi K; Chawla SP; Bouvet M; Singh SR; Tsuchiya H; Hoffman RM
Biochem Biophys Res Commun; 2019 May; 513(2):326-331. PubMed ID: 30955860
[TBL] [Abstract][Full Text] [Related]
5. Irinotecan and vincristine for the treatment of refractory desmoplastic small round cell tumor in a developing country: a case report.
Ambar NBD; de Seixas Alves MT; Lederman HM; Abib S; Duarte AAB; Caran EM
J Med Case Rep; 2019 Mar; 13(1):77. PubMed ID: 30851735
[TBL] [Abstract][Full Text] [Related]
6. Third-line trabectedin for a metastatic desmoplastic small round cell tumour treated with multimodal therapy.
Brunetti AE; Delcuratolo S; Lorusso V; Palermo L; Di Giorgio A; Pisconti S; Silvestris N
Anticancer Res; 2014 Jul; 34(7):3683-8. PubMed ID: 24982387
[TBL] [Abstract][Full Text] [Related]
7. Clinical Activity of Pazopanib in Patients with Advanced Desmoplastic Small Round Cell Tumor.
Menegaz BA; Cuglievan B; Benson J; Camacho P; Lamhamedi-Cherradi SE; Leung CH; Warneke CL; Huh W; Subbiah V; Benjamin RS; Patel S; Daw N; Hayes-Jordan A; Ludwig JA
Oncologist; 2018 Mar; 23(3):360-366. PubMed ID: 29212731
[TBL] [Abstract][Full Text] [Related]
8. Activity of trabectidin in desmoplastic small round cell tumor.
López-González A; Cantos B; Tejerina E; Provencio M
Med Oncol; 2011 Dec; 28 Suppl 1():S644-6. PubMed ID: 20924717
[TBL] [Abstract][Full Text] [Related]
9. Whole abdominopelvic intensity-modulated radiation therapy for desmoplastic small round cell tumor after surgery.
Pinnix CC; Fontanilla HP; Hayes-Jordan A; Subbiah V; Bilton SD; Chang EL; Grosshans DR; McAleer MF; Sulman EP; Woo SY; Anderson P; Green HL; Mahajan A
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):317-26. PubMed ID: 22104361
[TBL] [Abstract][Full Text] [Related]
10. Multiagent chemotherapy including IrIVA regimen and maintenance therapy in the treatment of desmoplastic small round cell tumor.
Ferrari A; Bergamaschi L; Chiaravalli S; Pecori E; Diletto B; Alessandro O; Giandini T; Livellara V; Sironi G; Casanova M
Tumori; 2022 Feb; 108(1):93-97. PubMed ID: 33594944
[TBL] [Abstract][Full Text] [Related]
11. Trabectedin in advanced desmoplastic round cell tumors: a retrospective single-center series.
Verret B; Honore C; Dumont S; Terrier P; Adam J; Cavalcanti A; Sourrouille I; Klausner G; Ahlenc-Gelas M; Kiavue N; Domitrescu G; El Amarti L; Mir O; Le Cesne A
Anticancer Drugs; 2017 Jan; 28(1):116-119. PubMed ID: 27782906
[TBL] [Abstract][Full Text] [Related]
12. Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour.
Stacchiotti S; Saponara M; Frapolli R; Tortoreto M; Cominetti D; Provenzano S; Negri T; Dagrada GP; Gronchi A; Colombo C; Vincenzi B; Badalamenti G; Zuco V; Renne SL; Collini P; Morosi C; Dei Tos AP; Bello E; Pilotti S; Casali PG; D'Incalci M; Zaffaroni N
Eur J Cancer; 2017 May; 76():84-92. PubMed ID: 28284173
[TBL] [Abstract][Full Text] [Related]
13. Trabectedin overcomes doxorubicin-resistance, counteracts tumor-immunosuppressive reprogramming of monocytes and decreases xenograft growth in Hodgkin lymphoma.
Casagrande N; Borghese C; Favero A; Vicenzetto C; Aldinucci D
Cancer Lett; 2021 Mar; 500():182-193. PubMed ID: 33326840
[TBL] [Abstract][Full Text] [Related]
14. Combination of Trabectedin With Irinotecan, Leucovorin and 5-Fluorouracil Arrests Primary Colorectal Cancer in an Imageable Patient-derived Orthotopic Xenograft Mouse Model.
Zhu G; Zhao M; Han Q; Tan Y; Sun YU; Bouvet M; Clary B; Singh SR; Ye J; Hoffman RM
Anticancer Res; 2019 Dec; 39(12):6463-6470. PubMed ID: 31810910
[TBL] [Abstract][Full Text] [Related]
15. Combination of trabectedin and irinotecan is highly effective in a human rhabdomyosarcoma xenograft.
Riccardi A; Meco D; Ubezio P; Mazzarella G; Marabese M; Faircloth GT; Jimeno J; D'Incalci M; Riccardi R
Anticancer Drugs; 2005 Sep; 16(8):811-5. PubMed ID: 16096428
[TBL] [Abstract][Full Text] [Related]
16. Combination treatment with trabectedin and irinotecan or topotecan has synergistic effects against ovarian clear cell carcinoma cells.
Kawano M; Mabuchi S; Kishimoto T; Hisamatsu T; Matsumoto Y; Sasano T; Takahashi R; Sawada K; Takahashi K; Takahashi T; Hamasaki T; Kimura T
Int J Gynecol Cancer; 2014 Jun; 24(5):829-37. PubMed ID: 24844217
[TBL] [Abstract][Full Text] [Related]
17. Protocol for the 2ND-STEP study, Japan Clinical Oncology Group study JCOG1802: a randomized phase II trial of second-line treatment for advanced soft tissue sarcoma comparing trabectedin, eribulin and pazopanib.
Endo M; Kataoka T; Fujiwara T; Tsukushi S; Takahashi M; Kobayashi E; Yamada Y; Tanaka T; Nezu Y; Hiraga H; Wasa J; Nagano A; Nakano K; Nakayama R; Hamada T; Kawano M; Torigoe T; Sakamoto A; Asanuma K; Morii T; Machida R; Sekino Y; Fukuda H; Oda Y; Ozaki T; Tanaka K
BMC Cancer; 2023 Mar; 23(1):219. PubMed ID: 36890471
[TBL] [Abstract][Full Text] [Related]
18. Clinical activity of sunitinib in patients with advanced desmoplastic round cell tumor: a case series.
Italiano A; Kind M; Cioffi A; Maki RG; Bui B
Target Oncol; 2013 Sep; 8(3):211-213. PubMed ID: 23292310
[TBL] [Abstract][Full Text] [Related]
19. Olaparib and temozolomide in desmoplastic small round cell tumors: a promising combination in vitro and in vivo.
van Erp AEM; van Houdt L; Hillebrandt-Roeffen MHS; van Bree NFHN; Flucke UE; Mentzel T; Shipley J; Desar IME; Fleuren EDG; Versleijen-Jonkers YMH; van der Graaf WTA
J Cancer Res Clin Oncol; 2020 Jul; 146(7):1659-1670. PubMed ID: 32279088
[TBL] [Abstract][Full Text] [Related]
20. Novel patient-derived models of desmoplastic small round cell tumor confirm a targetable dependency on ERBB signaling.
Smith RS; Odintsov I; Liu Z; Lui AJ; Hayashi T; Vojnic M; Suehara Y; Delasos L; Mattar MS; Hmeljak J; Ramirez HA; Shaw M; Bui G; Hartono AB; Gladstone E; Kunte S; Magnan H; Khodos I; De Stanchina E; La Quaglia MP; Yao J; Laé M; Lee SB; Spraggon L; Pratilas CA; Ladanyi M; Somwar R
Dis Model Mech; 2022 Jan; 15(1):. PubMed ID: 34841430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
